PAFAH (PLA2G7) (NM_001168357) Human Recombinant Protein

CAT#: TP720487L

Recombinant protein of human phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7), transcript variant 2.

Specifications

Product Data

• Species: Human
• Expression Host: HEK293
• Expression cDNA Clone or AA Sequence:
  Protein Sequence

  Phe22-Asn441
• Tag: C-His
• Predicted MW: 48.8 kDa
• Concentration: lot specific
• Purity: >95% as determined by SDS-PAGE and Coomassie blue staining
• Buffer: Supplied as a 0.2 μm filtered solution of 20mM HAc-NaCl, 150mM NaCl, 10% Glycerol, pH 4.5.
• Endotoxin: < 0.1 EU per µg protein as determined by LAL test
• Storage: Store at -80°C.
• Stability: Stable for at least 3 months from date of receipt under proper storage and handling conditions.

Reference Data

• RefSeq: NP_001161829
• Locus ID: 7941
• UniProt ID: Q13093
• Cytogenetics: 6p12.3
• Synonyms: LDL-PLA2; LP-PLA2; PAFAD; PAFAH
• Summary: The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2009]
• Protein Families: Druggable Genome, Secreted Protein
• Protein Pathways: Ether lipid metabolism, Metabolic pathways